subject area of
- A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer Academic Article
- CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern Academic Article
- Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer Academic Article
- Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis Academic Article
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy Academic Article
- Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review Academic Article
- Lung cancer. Academic Article
- NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer Academic Article
- Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse Academic Article
- Pharmacoeconomics of Systemic Therapies for Lung Cancer Academic Article
- Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease Academic Article
- Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer Academic Article
- Resource Use in the Last Three Months of Life by Lung Cancer Patients in Southern Ontario Academic Article
- Selecting Patients with Extensive-Stage Small Cell Lung Cancer for Prophylactic Cranial Irradiation by Predicting Brain Metastases Academic Article
- The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, Canada Conference Paper
- Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study Academic Article